fb-pixel tracker
News

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

Partnership combines Caris’ somatic and Ambry’s germline testing strengths to provide clinicians with unique information about the molecular and genetic components of a patient’s cancer   IRVING, Texas and ALISO VIEJO, Calif., December 4, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, and Ambry Genetics … Continued

University of Minnesota Joins Precision Oncology Alliance Led by Caris Life Sciences

University of Minnesota Masonic Cancer Center becomes 31st member of Caris’ collaborative network dedicated to advancing the role of precision medicine in cancer treatment   IRVING, Texas & MINNEAPOLIS, Minn., November 26, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that the … Continued

Caris Life Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference

IRVING, Texas, November 20, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brian J. Brille, Vice Chairman of the Company, will present at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 12:50 p.m. Eastern Time at … Continued

Caris Life Sciences to Present at Two Investor Healthcare Conferences

IRVING, Texas, November 7, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brian J. Brille, Vice Chairman of the Company, will present at two upcoming investor healthcare conferences in New York City. Presentation details are as follows:   Stifel 2019 Healthcare … Continued

St. Joseph Hospital Joins Caris Life Sciences’ Precision Oncology Alliance

St. Joseph Hospital’s Center for Cancer Prevention and Treatment becomes member of Caris’ collaborative network dedicated to making cancer treatment more precise and effective   IRVING, Texas & ORANGE, Calif., October 30, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that St. … Continued

Caris Life Sciences Further Bolsters Scientific Advisory Board With Four New Members

Industry thought leaders join a distinguished group of experts to advance Caris’ mission to expand the role of precision medicine in cancer care   IRVING, Texas, October 15, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today the addition of four members to its Scientific … Continued

Caris Life Sciences to Present New Research Across Tumor Types at ESMO Congress 2019

Presentations include findings on biomarkers in rare, untreatable form of testicular cancer, and analysis of differential responses to BRAF inhibitors in melanoma and colorectal cancers   IRVING, Texas, September 19, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that it will present … Continued

Caris Life Sciences to Present at Canaccord Genuity Annual Growth Conference

IRVING, Texas, July 31, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian J. Brille, Vice Chairman of the Company, will present at the Canaccord Genuity’s 38th Annual Growth Conference on Wednesday, August 7, 2019, at 10 a.m. Eastern time. The … Continued

1 2 3 21

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.